Table 4.
Baseline characteristics and assessment of cardiovascular and atherosclerosis markers in patients with a SALT score ≥ 50% compared to the healthy controls.
| Parameter | Patients with SALT score ≥ 50% (n = 25) | Healthy Controls (n = 20) |
Statistical Significance |
|---|---|---|---|
| Cardiovascular and Atherosclerosis Markers | |||
| MPO (ng/mL), median (IQR) | 82.78 (57.53–123.3) | 78.95 (45.55–129.4) | 0.48 |
| IL1RL1 (pg/mL), median (IQR) | 4513 (3966–6775) | 4666 (3886–5193) | 0.39 |
| GDF15 (pg/mL), median (IQR) | 37.57 (23.57–74.32) | 37.35 (25.51–42.92) | 0.67 |
| CCL4 (pg/mL), mean ± SD | 371.58 ± 181.81 | 303.82 ± 176.08 | 0.22 |
| CCL7 (pg/mL), median (IQR) | 38.91 (29.36–53.67) | 28.45 (21.52–36.59) | 0.11 |
| SORT1 (pg/mL), median (IQR) | 300.15 (281.1–314.35) | 312 (296.6–321.4) | 0.12 |
| Demographic and Clinical Data | |||
| Age (years), mean ± SD | 39 ± 15 | 37 ± 10 | 0.58 |
| Sex (women), n (%) | 19 (76%) | 14 (65%) | 0.65 |
| BMI (kg/m2), median (IQR) | 22.46 (20.70–25.28) | 21.29 (19.46–25.37) | 0.45 |
| Smoking (yes), n (%) | 4 (16%) | 4 (20%) | 0.72 |
| Family history (yes), n (%) | 4 (16%) | 3 (15%) | 0.92 |
| Laboratory Parameters | |||
| Glucose (mg/dL), mean ± SD | 87 ± 7 | 85 ± 9 | 0.55 |
| Cholesterol (mg/dL), mean ± SD | 189 ± 48 | 192 ± 34 | 0.78 |
| LDL cholesterol (mg/dL), mean ± SD |
113 ± 39 | 119 ± 30 | 0.57 |
| HDL cholesterol (mg/dL), mean ± SD | 70 ± 22 | 69 ± 19 | 0.97 |
| Triglycerides (mg/dL), median (IQR) |
95 (68–140) | 89 (58–139) | 0.34 |